HIF-1 and tumor progression: Pathophysiology and therapeutics

Trends in Molecular Medicine

Volumn 8, Issue 4 SUPPL., 2002, Pages

  Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN INHIBITOR; PROTEIN SUBUNIT;

ADAPTATION; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER MORTALITY; CARCINOGENESIS; DRUG EFFICACY; DRUG TARGETING; ENDOTHELIUM CELL; GENE MUTATION; GENE OVEREXPRESSION; GLYCOLYSIS; HUMAN; HYPOXIA; NONHUMAN; ONCOGENE; OXYGEN SUPPLY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; TREATMENT FAILURE; TUMOR BIOPSY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; DISEASE PROGRESSION; DNA-BINDING PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; OXYGEN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0036216692     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02317-1     Document Type: Review

References (37)

1. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
2. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects
3. Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology
4. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells
5. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1 α
6. Suppression of tumor growth through disruption of hypoxia-inducible transcription
7. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
8. 2 sensing
9. 2-regulated prolyl hydroxylation
10. HIF-1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
11. FIH-1: A novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
12. Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch
13. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
14. Modulation of HIF-1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/ AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
15. Loss of PTEN facilitates HIF-1-mediated gene expression
16. The expression and distribution of the hypoxia-inducible transcription factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
17. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
18. 2 homeostasis by hypoxia-inducible factor 1α
19. Hypoxia-inducible factor-1 (HIF-1) mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKBF3) gene: Its possible role in the Warburg effect
20. Expression of hypoxia-inducible factor 1α in brain tumors: Association with angiogenesis, invasion, and progression
21. Expression of hypoxia-inducible factor- 1α in oligodendrogliomas: Its impact on prognosis and on neoangiogenesis
22. Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: Its impact on prognosis and on response to chemotherapy
23. Levels of hypoxia-inducible factor-1α during breast carcinogenesis
24. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
25. Expression of hypoxia-inducible factor- 1α: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer
26. Hypoxia inducible factor (HIF-1 a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy
27. Hypoxia-inducible factor (HIF- 1) and its relationship to apoptosis and proliferation in lung cancer
28. Relation of hypoxia inducible factor 1αand 2αin operable non-small cell lung cancer to angiogenic/ molecular profile of tumours and survival
29. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation, and tumour angiogenesis
30. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia
31. Constitutive expression of hypoxia-inducible factor-1α renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation
32. ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor- 1α (HIF-1α) and inhibits HIF-1-mediated transcription
33. Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies
34. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1α, HIF-2α, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway
35. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
36. Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy
37. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension